TXGHealthcareMid-Cap
10x Genomics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for 10x Genomics, Inc. (TXG), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are TXG insiders buying or selling?
10x Genomics, Inc. insiders reported 6 open-market buys ($31.2M) and 248 sells ($871.4M) across 254 Form 4 filings — a net selling position of $840.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of Aug 28, 2026)
Total Form 4 filings
254
SEC EDGAR
Insider filers
16
Insider buys (6)
$31.2M
Insider sells (248)
$871.4M
Insider sentiment
Net sellingNet insider flow of $840.3M in net selling.
Recent TXG insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 28, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 10.5K | $63.69 | $667.9K |
| Aug 26, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 18.5K | $63.02 | $1.2M |
| Aug 26, 2026 | Adam Taich | Chief Financial Officer | Sale | 17.2K | $63.02 | $1.1M |
| Aug 26, 2026 | Benjamin J. Hindson | Title: President and Chief Scientific Officer | Sale | 13.8K | $63.02 | $870.9K |
| Aug 26, 2026 | Shehnaaz Suliman | Director | Sale | 2.2K | $63.65 | $140.5K |
| Aug 17, 2026 | Sarah A. Teichmann | Director | Sale | 7.6K | $57.25 | $432.3K |
| Aug 13, 2026 | John R Stuelpnagel | Director | Sale | 20.0K | $57.75 | $1.2M |
| Jun 24, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 30.0K | $34.44 | $1.0M |
| Jun 18, 2026 | Shehnaaz Suliman | Director | Sale | 5.7K | $32.63 | $186.8K |
| May 27, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 28.9K | $24.54 | $709.1K |
| May 27, 2026 | Benjamin J. Hindson | Title: President and Chief Scientific Officer | Sale | 11.6K | $24.44 | $283.4K |
| May 27, 2026 | Adam Taich | Chief Financial Officer | Sale | 15.1K | $24.44 | $369.0K |
| Apr 16, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 5.0K | $24.56 | $122.8K |
| Mar 25, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 15.0K | $19.26 | $288.9K |
| Mar 4, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 16.2K | $22.73 | $367.1K |
| Feb 27, 2026 | Sarah A. Teichmann | Director | Sale | 7.6K | $19.41 | $147.1K |
| Feb 25, 2026 | Serge Saxonov | Chief Executive Officer | Sale | 9.6K | $18.58 | $178.9K |
| Feb 25, 2026 | Adam Taich | Chief Financial Officer | Sale | 9.0K | $18.58 | $166.6K |
| Feb 25, 2026 | Benjamin J. Hindson | Title: President and Chief Scientific Officer; Exhibit 24.1 - Power of Attorney | Sale | 7.8K | $18.58 | $145.4K |
| Nov 25, 2025 | Adam Taich | Chief Financial Officer | Sale | 11.9K | $19.00 | $225.9K |
| Nov 25, 2025 | Benjamin J. Hindson | President and Chief Scientific Officer | Sale | 8.3K | $19.00 | $157.4K |
| Nov 25, 2025 | Serge Saxonov | Chief Executive Officer | Sale | 13.3K | $19.00 | $251.9K |
| Aug 26, 2025 | Serge Saxonov | Chief Executive Officer | Sale | 9.3K | $13.79 | $128.9K |
| Aug 26, 2025 | Adam Taich | Chief Financial Officer | Sale | 22.3K | $13.79 | $307.7K |
| Aug 26, 2025 | Benjamin J. Hindson | President and Chief Scientific Officer | Sale | 7.5K | $13.79 | $103.2K |
Showing the 25 most recent of 254 Form 4 filings for 10x Genomics, Inc..
Most active TXG insiders
- Serge Saxonov67 filings
- Benjamin J. Hindson47 filings
- John R Stuelpnagel39 filings
- Justin J. Mcanear37 filings
- Bradford Crutchfield30 filings
Ask anything about TXG insider activity
Use Trabud's AI agent to query 10x Genomics, Inc.'s Form 4 history in plain English — "Show me TXG CEO purchases this year" or compare it against any other ticker.
Open the AI agentTXG insider trading FAQ
Are 10x Genomics, Inc. insiders buying or selling?
Across 254 SEC Form 4 filings, 10x Genomics, Inc. (TXG) insiders reported 6 open-market purchases totaling $31.2M and 248 sales totaling $871.4M. That is a net selling position of $840.3M.
How many insiders trade TXG stock?
16 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for 10x Genomics, Inc.. The most recent filing was accepted on Aug 28, 2026.
Where does Trabud get TXG insider trading data?
All TXG insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.